Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA Testing

SWOG Cancer Research Network · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
breastcancer
hr positive/her-2 negative breast cancer, metastatic, breast cancer, capivasertib, hr positive, her2 negative, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 854173
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.